
Bioorganic and Medicinal Chemistry Letters p. 881 - 886 (1997)
Update date:2022-08-04
Topics:
Peglion, Jean-Louis
Vian, Joel
Goument, Bertrand
Despaux, Nicole
Audinot, Valerie
Millan, Mark J.
Starting from the structure of the preferential D3 antagonist S 14297 (1), we have prepared a series of cis and trans tetracyclic derivatives of general formula I in order to improve potency and selectivity for D3 receptors. The trans oxazino derivative 2c, showed slightly increased affinity at D3 receptors and double the selectivity for D3 over D2 receptors, in comparison to S 14297. Cis derivatives and compounds where R1 is aralkyl were totally devoid of activity.
View MoreContact:0027-717-456976
Address:2ND FLOOR, 325 VAUSE ROAD, OVERPORT, 4001, SOUTH AFRICA
Goldwills Pharmaceuticals Co., Ltd.
Contact:0916-2237889 13991621155
Address:North Suburb of Hanzhong city, Shaanxi Province
Hangzhou Gangjin Chemical Co.,Ltd.(expird)
Contact:+86-571-85109780
Address:707 Zhejiang Minhang Bldg., No.290 Zhongshan North Road, Hangzhou 310003, China
Hebei Lead Bio-Chemicals Co., Ltd.
website:http://www.ldbiochem.com
Contact:+86-311-87826503
Address:481, Heping West Road, Shijiazhuang,China
Guangxi Bonger Pharmaceutical Co., Ltd
website:http://napo.lookchem.com/
Contact:+86-18817331185
Address:Donghai Industrial Zone, Tiandong Country,Guangxi,China
Doi:10.1016/S0014-827X(99)00017-8
(1999)Doi:10.1016/j.poly.2010.12.049
(2011)Doi:10.1016/j.tetlet.2008.03.138
(2008)Doi:10.1039/DT9900002321
(1990)Doi:10.1002/ardp.200400884
(2004)Doi:10.1016/j.bmcl.2011.02.058
(2011)